Lovell Stephanie insider trades

Lovell Stephanie has filed 8 Form 4s with the SEC that we hold, for TransMedics Group, Inc. (TMDX) (Director) and Korsana Biosciences, Inc. (CYCN) (Director). Across all of them we count 0 purchases worth $0 and 4 sales worth $799.2K reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($178.5K). The largest single trade was a sale of 5,657 shares of TransMedics Group, Inc. worth $336.6K, dated 2022-11-23. The first filing on our record is dated 2022-06-06 and the latest 2026-05-22.

TransMedics Group, Inc. (TMDX)

Director · 7 filings · 4 purchases and sales

Trade date	Code	Shares	Value as filed	Filed	Source
2022-11-22	S, sale reported on Form 4	1,100	$63.8K	2022-11-23	SEC
2022-11-22	S, sale reported on Form 4	3,800	$220.3K	2022-11-23	SEC
2022-11-23	S, sale reported on Form 4	5,657	$336.6K	2022-11-23	SEC
2026-03-04	S, sale reported on Form 4	1,193	$178.5K	2026-03-06	SEC

Korsana Biosciences, Inc. (CYCN)

Director · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1772054) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-27 · For informational purposes only, not investment advice.
Privacy · Terms